Biopharmaceutical Bioseparation Systems - Global Strategic Business Report

  • ID: 3619380
  • Report
  • Region: Global
  • 294 pages
  • Global Industry Analysts, Inc
1 of 4

FEATURED COMPANIES

  • 3M Company (USA)
  • Merck KGaA (Germany)
  • Pall Corporation (USA)
  • YMC Europe GmbH (Germany)
  • MORE

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments:

  • Chromatography Systems
  • Other Bioseparation Systems

Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as:

  • 3M Company
  • Agilent Technologies, Inc.
  • Alfa Wassermann Separation Technologies, LLC
  • Flottweg Separation Technology
  • GEA Westfalia Separator Group GmbH
  • GE Healthcare Life Sciences
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Company (USA)
  • Merck KGaA (Germany)
  • Pall Corporation (USA)
  • YMC Europe GmbH (Germany)
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK
Bioseparation Systems
Invaluable Tools in Biopharmaceutical Manufacturing
US Remains Market Leader; Developing Countries to Drive Market Growth
Chromatography Leads the Pack
Global Market for Gas Chromatography Systems
Competitive Landscape
Table 1: Leading Players in the Global Biopharmaceutical Bioseparation Systems Market (2017): Percentage Market Share Breakdown of Revenues for 3M Purification, GE Healthcare Life Sciences, Merck, Pall Corporation, Sartorius and Others (includes corresponding Graph/Chart)

2. INDUSTRY OVERVIEW
A Peek into Biopharmaceutical Manufacturing
Downstream Processing of Biosynthetic Products
An Overview
Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
Table 2: Top 10 Biopharmaceutical Companies: 2016 (includes corresponding Graph/Chart)
Table 3: CDER NME NDAs/BLAs Filings and Approvals: As of November 30, 2017 (includes corresponding Graph/Chart)
New Biologic License Application (BLA) Approvals-2017
New Biologic License Application (BLA) Approvals: 2016
New Biologic License Application (BLA) Approval: 2015
Biopharmaceutical Industry Transforms Downstream Processing
Growing Biological Drug Manufacturing Capacity to Drive Growth
Growing Market for Monoclonal Antibodies
A Key Review of Current Status and Future Prospects
Approved Monoclonal Antibodies: 2014-2017
An Insight into Bioseparation of mAbs
Growing Biosimilars Market
A Clear Advantage for Bioseparation Technologies
Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
US APPROVED BIOSIMILARS AS OF DECEMBER 2017
EUROPE APPROVED BIOSIMILARS AS OF DECEMBER 2017
R&D Funding Crucial for Biologics and Bioseparation Market
Huge Biopharmaceutical Pipeline
A Clear Indicator of Future Prospects
Table 4: Biopharmaceutical Products’ Pipeline by Therapeutic Category: As of August, 2016 (includes corresponding Graph/Chart)
Table 5: Biopharmaceutical Products’ Pipeline by Clinical Phase: As of August, 2016 (includes corresponding Graph/Chart)
Table 6: Biopharmaceutical Cancer Products Pipeline: As of August, 2016 (includes corresponding Graph/Chart)

3. BIOSEPARATION TECHNOLOGIES
KEY MARKET TRENDS
Increasing Need for Further Advances in Downstream Processing Techniques
Process Optimization and Cost Reduction
Key Goals of Innovations in Bioseparation
Continuous Bioseparation Gains Momentum
Process Intensification
Single-Use Systems Play a Key Role
Minimizing Centrifugation Steps
Integration of Down-Stream and Up-Stream
Developmental Efforts
Focus on Enhancing Capture Increases
Introduction of Diversified Resins on the Rise
Multicolumn System Lower Buffer and Resin Requirement
Single-Use Disposable Technologies Gain Attention
Select Commercial Disposable/Single-Use Technologies by Process Technique
Innovations in Single-use Systems
Increasing Biopharma Productivity and Efficiency via Continuous Manufacturing
Changing Paradigm of Primary Recovery in Bioseparation
Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
Chromatography
The Gold Standard Purification Technology
Continuous Chromatography- A Key Technology for the Biopharma Sector
Challenges to Separate Active Pharmaceutical Ingredients, Chromatography to the Rescue
Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
SMBC
An Old Approach Gaining Significant Attention
Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
A Comparison of Protein and Synthetic Ligands
Increasing Alternatives to Protein A Column based Capturing
Twin-Column SMB
An Emerging Alternative to Protein A Columns
Chiral Chromatography Increases in Popularity
Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
Chromatography Efficiency and Selectivity
Mixed-Mode Chromatography
Multimode Chromatography
Mixed-Mode and Multimode Media Offer Cost Savings
Awareness of Mixed Mode and Multimode Media Operating Modes Critical
Magnetic Separation as an Alternative to Chromatography
A Review
Reversible Precipitation
A Novel Bioseparation Technology

4. PRODUCT OVERVIEW
Biological Products
An Overview
Classification of Biological Products by Application
Classification of Biological Products by Chemical Nature
Bioseparation
An Overview
Commonly Used Bioseparation Processes by Factors
Bioseparation
A Challenging, Complex, and Expensive Process
Stages of Biomolecule Recovery and Relevant Bioseparation Techniques Used
Classification of Bioseparation Techniques based on Resolution and Throughput
Bioseparation Costs as a Percentage of Processing by Biological Product
Key Bioseparation Techniques
Chromatography
Centrifugation
Membrane Separation
Filtration
Overview of Other Bioseparation Techniques
Adsorption
Extraction
Precipitation
Classification of Bioseparation Techniques based on Physical Form
Particle-Liquid Separation
Particle-Particle Separation
Solute-Solvent Separation
Solute-Solute Separation
Liquid-Liquid Separation
Particle-Solute Separation
RIPP in Bioseparation
The Conventional Scheme for Developing Processes

5. PRODUCT INTRODUCTIONS/APPROVALS
GE Healthcare Introduces MabSelect PrismA
Pall Introduces Flexible Single-use Chromatography System
MilliporeSigma Launches Eshmuno Affinity Chromatography Resins
PerkinElmer Introduces Clarus 590 and 690 GC Instruments
Sartorius Stedim Biotech Releases Sartobind Cassettes
Ellutia Chromatography Solutions Unveils 500 Series Range of Instruments
Kaneka Corporation Launches KANEKA KanCapA 3G
Pall Life Sciences Introduces Cadence BioSMB Process System
Thermo Fisher Exhibits SMART Digest Kit
Merck Launches Wide Range of Products for Separation and Analysis
Agilent Technologies Introduces New Line of AdvanceBio SEC Columns

6. RECENT INDUSTRY ACTIVITY
Waters Corp. Launches ACQUITY Arc Bio System
GE Healthcare Acquires Puridify
MilliporeSigma Inks MoU with Samsung BioLogics
Merck Acquires Natrix Separations
Repligen Merges with Spectrum Labs
Waters Enters into a Co-Marketing Agreement with Wyatt Technology
JLS Expands Amsphere A3 Production Capacity
YMC Buys Land in the Annex Kyoto Miwa Industrial Park
KNAUER and 3B Pharmaceuticals Delivers Purification Process for Camelid Antibodies
ATG Enters into a Service Agreement with LEWA-Nikkiso America
Repligen Buys Atoll
Pall Enters into a Supply Agreement with KANEKA
Merck Acquires Sigma-Aldrich
EMD Millipore Launches Sterilizing-Grade Millipore Express® PHF Hydrophilic Filters
Anteo Diagnostics Inks South Korean Distribution Agreement with KomaBiotech
GE Healthcare and Sartorius Stedim Biotech Ink OEM Supply Agreement for Sartobind™ Technology
EMD Millipore Unveils Pellicon® Tangential Flow Filtration System
ImmunoReagents and ProteoVec Launch PV-Pure Ig™ Antibody Purification Kits
Pall Acquires Tarpon’s BioSMB Platform

7. FOCUS ON SELECT PLAYERS
3M Company (USA)
3M Purification, Inc. (USA)
Agilent Technologies, Inc. (USA)
Alfa Wassermann Separation Technologies, LLC (USA)
Flottweg Separation Technology (USA)
GEA Westfalia Separator Group GmbH (Germany)
GE Healthcare Life Sciences (USA)
KNAUER Wissenschaftliche Geräte GmbH (Germany)
Konik Nanobiotech SL (Spain)
Merck KGaA (Germany)
Pall Corporation (USA)
ProMetic Life Sciences, Inc. (Canada)
Sartorius Stedim Biotech (France)
Repligen Corporation (USA)
Thermo Fisher Scientific, Inc. (USA)
Tosoh Bioscience, Inc. (Japan)
YMC Europe GmbH (Germany)

8. GLOBAL MARKET PERSPECTIVE
Table 7: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 8: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 9: World 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 10: World Recent Past, Current & Future Analysis for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 11: World Historic Review for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 12: World 14-Year Perspective for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 13: World Recent Past, Current & Future Analysis for Other Biopharmaceutical Bioseparation Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 14: World Historic Review for Other Biopharmaceutical Bioseparation Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 15: World 14-Year Perspective for Other Biopharmaceutical Bioseparation Systems by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
United States: The Largest Biopharmaceutical Market Globally
Table 16: CDER NME NDAs/BLAs Filings and Approvals as of 11/30/17 (includes corresponding Graph/Chart)
Impending Patent Expiries Signal Growth Prospects
Leading US Biopharmaceuticals by Year of Patent Expiry
Product Launches
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 17: The US Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 18: The US Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 19: The US 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current & Future Analysis
Canada
A Lucrative Biopharmaceutical Industry
Strategic Corporate Development
Select Key Player
B.Market Analytics
Table 20: Canadian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 21: Canadian Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 22: Canadian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current & Future Analysis
Product Launch
Strategic Corporate Developments
Select Key Player
B.Market Analytics
Table 23: Japanese Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 24: Japanese Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 25: Japanese 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current & Future Analysis
Select Trends in the European Biopharmaceutical Industry
Funding Challenges Faced by Biopharmaceutical Startups
Healthcare Agencies Embrace Biosimilars to Cut Healthcare Costs
B.Market Analytics
Table 26: European Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 27: European Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 28: European 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region
Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 29: European Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 30: European Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 31: European 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Current & Future Analysis
Select Key Player
B.Market Analytics
Table 32: French Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 33: French Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 34: French 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Current & Future Analysis
Product Launch
Strategic Corporate Development
Select Key Players
B.Market Analytics
Table 35: German Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 36: German Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 37: German 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 38: Italian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 39: Italian Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 40: Italian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current & Future Analysis
Product Launch
Strategic Corporate Developments
B.Market Analytics
Table 41: The UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 42: The UK Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 43: The UK 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4e. SPAIN
A.Market Analysis
Current & Future Analysis
Select Key Player
B.Market Analytics
Table 44: Spanish Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 45: Spanish Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 46: Spanish 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4f. RUSSIA
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 47: Russian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 48: Russian Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 49: Russian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Strategic Corporate Development
B.Market Analytics
Table 50: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 51: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 52: Rest of Europe 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
Regional Biopharma Players Gain Strength by Innovation and Partnerships
Asia Set to Emerge as Preferred Outsourcing Destination for Biopharma Manufacturing
Availability of Scientific Talent
Major Advantage for India
B.Market Analytics
Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 54: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 55: Asia-Pacific 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region
Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 57: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 58: Asia-Pacific 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
5a. CHINA
Market Analysis
Table 59: Chinese Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 60: Chinese Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 61: Chinese 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
5b. INDIA
Market Analysis
Table 62: Indian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 63: Indian Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 64: Indian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
B.Market Analytics
Table 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 66: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 67: Rest of Asia-Pacific 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6. THE MIDDLE EAST & AFRICA
Market Analysis
Table 68: The Middle East & African Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 69: The Middle East & African Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 70: The Middle East & African 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7. LATIN AMERICA
Market Analysis
Table 71: Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region
Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 72: Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region
Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 73: Latin American 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region
Percentage Breakdown of Revenues for Brazil and Rest of Latin American Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 74: Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 75: Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 76: Latin American 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
7a. BRAZIL
Market Analysis
Table 77: Brazilian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 78: Brazilian Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 79: Brazilian 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
7b. REST OF LATIN AMERICA
Market Analysis
Table 80: Rest of Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 81: Rest of Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Segment
Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 82: Rest of Latin American 14-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment
Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 57 (including Divisions/Subsidiaries 68)

  • The United States (34)
  • Canada (2)
  • Japan (6)
  • Europe (21)
    • France (3)
    • Germany (10)
    • The United Kingdom (3)
    • Spain (1)
    • Rest of Europe (4)
  • Asia-Pacific (Excluding Japan) (5)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M Company (USA)
  • 3M Purification, Inc. (USA)
  • Agilent Technologies, Inc. (USA)
  • Alfa Wassermann Separation Technologies, LLC (USA)
  • Flottweg Separation Technology (USA)
  • GEA Westfalia Separator Group GmbH (Germany)
  • GE Healthcare Life Sciences (USA)
  • KNAUER Wissenschaftliche Geräte GmbH (Germany)
  • Konik Nanobiotech SL (Spain)
  • Merck KGaA (Germany)
  • Pall Corporation (USA)
  • ProMetic Life Sciences, Inc. (Canada)
  • Sartorius Stedim Biotech (France)
  • Repligen Corporation (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • Tosoh Bioscience, Inc. (Japan)
  • YMC Europe GmbH (Germany)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll